Study on Whole Abdominal Radiotherapy for Ovarian Cancer
Author Information
Author(s): Rochet Nathalie, Kieser Meinhard, Sterzing Florian, Krause Sonja, Lindel Katja, Harms Wolfgang, Eichbaum Michael H, Schneeweiss Andreas, Sohn Christof, Debus Juergen
Primary Institution: University of Heidelberg
Hypothesis
Can intensity-modulated whole abdominal radiotherapy improve tolerability in patients with advanced ovarian cancer after chemotherapy?
Conclusion
The study aims to evaluate the tolerability and toxicity of intensity-modulated whole abdominal radiotherapy in patients with advanced ovarian cancer.
Supporting Evidence
- Ovarian cancer has a poor prognosis despite aggressive treatment.
- Intensity-modulated radiotherapy may reduce toxicity compared to conventional methods.
- The study aims to demonstrate good tolerability of the new treatment approach.
Takeaway
This study is testing a new type of radiation therapy for women with advanced ovarian cancer to see if it is easier for them to handle than older methods.
Methodology
This is a single-center, one-arm phase II trial treating 37 patients with intensity-modulated whole abdominal radiotherapy.
Potential Biases
Potential bias due to the single-arm design and lack of control group.
Limitations
The study is limited to a single center and may not be generalizable to all populations.
Participant Demographics
Patients with advanced ovarian cancer stage FIGO III, optimally debulked, and in complete remission after chemotherapy.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website